UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment
June 16, 2025

(The Guardian) – Combination of two targeted drugs found to produce better outcomes and was more tolerable than chemotherapy
A groundbreaking UK-wide trial has found a chemotherapy-free approach to treating leukaemia that may lead to better outcomes for some patients, with the results being hailed as a “milestone”.
Led by researchers from Leeds, results from the Flair trial, which took place at 96 cancer centres across the UK, could reshape the way the most common form of leukaemia in adults is treated, scientists said.
The trial set out to assess whether two targeted cancer drugs could perform better than standard chemotherapy among patients with chronic lymphocytic leukaemia (CLL). (Read More)